These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 36813082)
41. Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far. Bordoloi D; Roy NK; Monisha J; Padmavathi G; Kunnumakkara AB Recent Pat Anticancer Drug Discov; 2016; 11(1):67-97. PubMed ID: 26537958 [TBL] [Abstract][Full Text] [Related]
42. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L. Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340 [TBL] [Abstract][Full Text] [Related]
43. Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil. Vinod BS; Antony J; Nair HH; Puliyappadamba VT; Saikia M; Narayanan SS; Bevin A; Anto RJ Cell Death Dis; 2013 Feb; 4(2):e505. PubMed ID: 23429291 [TBL] [Abstract][Full Text] [Related]
44. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168 [TBL] [Abstract][Full Text] [Related]
45. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling. Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104 [TBL] [Abstract][Full Text] [Related]
46. KIAA1549 promotes the development and chemoresistance of colorectal cancer by upregulating ERCC2. Ye F; Xie Y; Lin M; Liu Y; Fang Y; Chen K; Zhang Y; Ding Y Mol Cell Biochem; 2024 Mar; 479(3):629-642. PubMed ID: 37140813 [TBL] [Abstract][Full Text] [Related]
47. Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance. Jensen NF; Stenvang J; Beck MK; Hanáková B; Belling KC; Do KN; Viuff B; Nygård SB; Gupta R; Rasmussen MH; Tarpgaard LS; Hansen TP; Budinská E; Pfeiffer P; Bosman F; Tejpar S; Roth A; Delorenzi M; Andersen CL; Rømer MU; Brünner N; Moreira JM Mol Oncol; 2015 Jun; 9(6):1169-85. PubMed ID: 25759163 [TBL] [Abstract][Full Text] [Related]
48. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637. Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038 [TBL] [Abstract][Full Text] [Related]
49. A pre-existing population of ZEB2 Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865 [TBL] [Abstract][Full Text] [Related]
50. Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression. Yoshida K; Toden S; Ravindranathan P; Han H; Goel A Carcinogenesis; 2017 Oct; 38(10):1036-1046. PubMed ID: 29048549 [TBL] [Abstract][Full Text] [Related]
51. Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells. Montopoli M; Ragazzi E; Froldi G; Caparrotta L Cell Prolif; 2009 Apr; 42(2):195-206. PubMed ID: 19236381 [TBL] [Abstract][Full Text] [Related]
52. Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells. Wen S; Wang X; Wang Y; Shen J; Pu J; Liang H; Chen C; Liu L; Dai P Artif Cells Nanomed Biotechnol; 2018; 46(sup1):896-905. PubMed ID: 29475390 [TBL] [Abstract][Full Text] [Related]
53. Curcumin and colorectal cancer: An update and current perspective on this natural medicine. Weng W; Goel A Semin Cancer Biol; 2022 May; 80():73-86. PubMed ID: 32088363 [TBL] [Abstract][Full Text] [Related]
54. Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin. Nagourney RA; Evans S; Tran PH; Nagourney AJ; Sugarbaker PH Eur J Surg Oncol; 2021 Apr; 47(4):738-742. PubMed ID: 33004272 [TBL] [Abstract][Full Text] [Related]
55. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms. Ye MX; Zhao YL; Li Y; Miao Q; Li ZK; Ren XL; Song LQ; Yin H; Zhang J Phytomedicine; 2012 Jun; 19(8-9):779-87. PubMed ID: 22483553 [TBL] [Abstract][Full Text] [Related]
56. 6-Shogaol enhances the anticancer effect of 5-fluorouracil, oxaliplatin, and irinotecan via increase of apoptosis and autophagy in colon cancer cells in hypoxic/aglycemic conditions. Woźniak M; Makuch S; Winograd K; Wiśniewski J; Ziółkowski P; Agrawal S BMC Complement Med Ther; 2020 May; 20(1):141. PubMed ID: 32393373 [TBL] [Abstract][Full Text] [Related]
57. FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase Luo W; Liu Q; Chen X; Liu H; Quan B; Lu J; Zhang K; Wang X Biomed Res Int; 2021; 2021():9986376. PubMed ID: 34212047 [TBL] [Abstract][Full Text] [Related]
58. miR-122 Targets X-Linked Inhibitor of Apoptosis Protein to Sensitize Oxaliplatin-Resistant Colorectal Cancer Cells to Oxaliplatin-Mediated Cytotoxicity. Hua Y; Zhu Y; Zhang J; Zhu Z; Ning Z; Chen H; Liu L; Chen Z; Meng Z Cell Physiol Biochem; 2018; 51(5):2148-2159. PubMed ID: 30522111 [TBL] [Abstract][Full Text] [Related]
59. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways. Sivanantham B; Sethuraman S; Krishnan UM ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786 [TBL] [Abstract][Full Text] [Related]
60. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin. Bommer UA; Vine KL; Puri P; Engel M; Belfiore L; Fildes K; Batterham M; Lochhead A; Aghmesheh M Cell Commun Signal; 2017 Feb; 15(1):9. PubMed ID: 28143584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]